Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBA-Itraconazole for Refractory or Intolerant Coccidioidomycosis
NCT04809649Phase 2Withdrawn
- Start
- May 2021
- Primary completion
- Sep 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of SUBA itraconazole in coccidioidomycosis. Planned start May 2021; status: withdrawn.
02
Drugs
SUBA itraconazole
03
Conditions
coccidioidomycosis
Beyond the preview
Go deeper on NCT04809649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04809649.